Biosensors - 03/12/2019 Learning from honey bees Biosensors are used in medical diagnostics and food and environmental analyses, to name just a few examples. apic.ai, a start-up based in Karlsruhe, uses honey bees as bioindicators to gain insights into the state of the ecosystem. The company also uses artificial intelligence (AI) methods for their ecotoxicological investigations.https://www.biooekonomie-bw.de/en/articles/news/learning-from-the-bees
Article - 10/01/2019 Stocktaking and recommendations for action: the BBAW’s fourth gene technology report In the new gene technology report, the interdisciplinary working group of the Berlin-Brandenburg Academy of Sciences (BBAW) takes stock of gene technology developments in Germany during the past few decades, and discusses the societal, legal and ethical challenges associated with these technologies in the future. The report is highly topical due to the controversy surrounding the ruling of the European Court of Justice on CRISPR/Cas9 genome…https://www.biooekonomie-bw.de/en/articles/news/stocktaking-and-recommendations-for-action-the-bbaws-fourth-gene-technology-report
Press release - 30/04/2013 Impressions from the 2013 BIO International Convention in Chicago A trade fair turns 20 and an industrial sector is coming of age. Where does BIO stand today? The number of exhibitors has slightly decreased the conference is characterised by general themes and trends and partnering has become the most important and indispensable part of the global event for biotechnology. What was once a gold rush atmosphere has given way to an experienced self-confidence about the economic importance of biotechnology. https://www.biooekonomie-bw.de/en/articles/pm/impressions-from-the-2013-bio-international-convention-in-chicago
Dossier - 25/03/2013 Biotechnology goes automated Processes that previously required pipetting analysis and production to be carried out manually are increasingly now controlled by automated systems. However this has not necessarily involved a complete reinvention of the wheel instead automation systems used in the plant construction and mechanical engineering sectors are being adapted and optimised for application in the life sciences. https://www.biooekonomie-bw.de/en/articles/dossiers/biotechnology-goes-automated
Article - 15/10/2012 gerbion®: hunting down pathogens Detecting viruses, bacteria or parasites in human, animal, food and environmental samples is routine for the staff of gerbion GmbH & Co. KG. The company has been using virological, microbiological and serological methods for many years, but is now also using cutting-edge molecular biology methods for detecting pathogens. The founders of the Kornwestheim-based diagnostics company have concentrated on own research work and the development of…https://www.biooekonomie-bw.de/en/articles/news/gerbion-hunting-down-pathogens
Article - 06/02/2012 Ten outstanding ideas in biotechnology and medical technology The results of the feasibility studies funded under the Idea Competition in Biotechnology and Medical Technology were presented in the Haus der Wirtschaft in Stuttgart between 16th and 18th January 2012. Ten of the 42 project ideas were recommended for further funding.https://www.biooekonomie-bw.de/en/articles/news/ten-outstanding-ideas-in-biotechnology-and-medical-technology
Dossier - 18/10/2010 New machines for the life sciences Hardware and software applications have become an integral part of the everyday life of life sciences researchers, developers and service providers. It is impossible to imagine life science applications without effective hardware and software applications – from computer-assisted drug screening to the automatic production of biosensors for rapid, mobile, purse-size bacterial test devices. Trends such as automation and miniaturisation lead to ever…https://www.biooekonomie-bw.de/en/articles/dossiers/new-machines-for-the-life-sciences
Article - 28/06/2010 ATG:biosynthetics GmbH – Modular molecular systems of the future ATGbiosynthetics GmbH based in Merzhausen close to Freiburg produces biological systems that can combine gene constituents following a construction kit principle. The company provides the pharmaceutical industry and basic researchers with products that have specifically chosen properties.https://www.biooekonomie-bw.de/en/articles/news/atg-biosynthetics-gmbh-modular-molecular-systems-of-the-future
Dossier - 16/07/2009 Patents – the exploitations of inventions in the life sciences According to statistics from the European Patent Office a total of 1065 biotechnological patents were filed in 2007 by inventors based in Germany. This puts Germany second behind the USA. In the coming years experts expect that a much larger number of biotech patents will be filed. For life sciences inventors the registration of patents quite often represents a real challenge. People entering the world of patents and licences are faced with a…https://www.biooekonomie-bw.de/en/articles/dossiers/patents-the-exploitations-of-inventions-in-the-life-sciences
Article - 09/06/2009 We would gladly finance more biotechs For four years, the High-Tech Gründerfonds (high-tech company establishment fund) has been supporting technology-oriented company founders. The project, which is backed by the Federal German government and major businesses, has 272 million euros of largely federal funds at its disposal, and its objective is the accelerated marketability of ideas. We spoke with Marco Winzer, representative and Investment Director at High-Tech Gründerfonds,…https://www.biooekonomie-bw.de/en/articles/news/we-would-gladly-finance-more-biotechs
Article - 18/05/2009 Less chemistry and fresher fruits and vegetables At Lake Constance fruit growers have bigger problems to face than ideological discussions on biotechnology and genetic engineering. They need methodological solutions for devastating plant diseases that would help them reduce the use of chemicals.https://www.biooekonomie-bw.de/en/articles/news/less-chemistry-and-fresher-fruits-and-vegetables
Article - 09/06/2008 Moderate growth In 2007 the German biotechnology sector was marked by moderate growth. Turnover climbed over two billion euros and research and development expenditure reached one billion euros. These are the central findings of the latest company survey carried out by biotechnologie.de.https://www.biooekonomie-bw.de/en/articles/news/moderate-growth
Press release - 26/04/2008 Curetis AG - Compact weapon against tuberculosis In conjunction with reference laboratories of the World Health Organization WHO medtech company Curetis AG is developing new technologies and products that identify the pathogens of infectious diseases such as tuberculosis and their resistance. The solutions are impressive. https://www.biooekonomie-bw.de/en/articles/pm/curetis-ag-compact-weapon-against-tuberculosis